Stephanie Dwyer Kaluzna(@StephDwyer21) 's Twitter Profileg
Stephanie Dwyer Kaluzna

@StephDwyer21

Asst Prof UIC COP | Cardiology Pharmacist UI Health | Irish Dance enthusiast | Teaching Philosophy: The Office S5, Ep14, 0:33-0:43 sec | she/her

ID:1174364849846898688

calendar_today18-09-2019 16:49:44

632 Tweet

925 Takipçi

375 Takip Edilen

JACC Journals(@JACCJournals) 's Twitter Profile Photo

LBCT SimPub: First randomized, cross-over study examining the effectiveness of 3 diuretic regimens in the setting of an in-hospital HF day-care unit bit.ly/3wyAafV
🔹IV furosemide
🔹IV furosemide+oral metolazone
🔹IV furosemide+IV acetazolamide

#HeartFailure2024 #JACCHF LBCT SimPub: First randomized, cross-over study examining the effectiveness of 3 diuretic regimens in the setting of an in-hospital HF day-care unit bit.ly/3wyAafV 🔹IV furosemide 🔹IV furosemide+oral metolazone 🔹IV furosemide+IV acetazolamide
account_circle
Hema Krishna, MD(@HemaKrishnaMD) 's Twitter Profile Photo

University of Illinois at Chicago is hiring a lead sonographer for our outpatient laboratory! Looking for a candidate with academic (education/research) experience, organizational skills to oversee 3 sites, and enthusiasm to build the program. Apply here: uic.csod.com/ux/ats/careers…

account_circle
ACCP Cardiology PRN(@accpcardprn) 's Twitter Profile Photo

Hi students! It’s the first Tuesday of May, which means it’s time to start our NAPLEX review series📚

Which of the following is a guideline-recommended beta-blocker for patients with HFrEF?

account_circle
Dr. Martha Gulati ♥️🫀❤️‍🩹🇨🇦(@DrMarthaGulati) 's Twitter Profile Photo

RELIEVE HF trial
🫀interatrial shunt in HF with any LVEF RCT: No difference in primary endpoint between the groups
🫀508 patients: randomized to device vs placebo: blinded!
🫀No difference in QOL but improved in both
🫀 did differ in HFrEF vs HFpEF: ⬆️ LVEF ⬆️harm

RELIEVE HF trial #ACC24 #LBCT 🫀interatrial shunt in HF with any LVEF RCT: No difference in primary endpoint between the groups 🫀508 patients: randomized to device vs placebo: blinded! 🫀No difference in QOL but improved in both 🫀 did differ in HFrEF vs HFpEF: ⬆️ LVEF ⬆️harm
account_circle
Stephanie Dwyer Kaluzna(@StephDwyer21) 's Twitter Profile Photo

Hey members! It’s time to refresh those diagnostic skills!

Join IllinoisACC this Wednesday 3/6 at 6 PM CST for their diagnostic webinar series. They’re covering stress tests, GLS, and echocardiography in AS!

Register here 👇🏼
events.r20.constantcontact.com/register/event…

Hey #ACCCVT members! It’s time to refresh those diagnostic skills! Join @IllinoisACC this Wednesday 3/6 at 6 PM CST for their diagnostic webinar series. They’re covering stress tests, GLS, and echocardiography in AS! Register here 👇🏼 events.r20.constantcontact.com/register/event…
account_circle
Aaron Schwartz(@A_Schwa) 's Twitter Profile Photo

The strangest case of my primary care career began with an electronic patient request.

I get these a lot. 99% are med refills, forms, or questions about symptoms. This was different. My patient felt fine. But, he was worried he’d be sent to jail…

1/13

account_circle
Stephanie Dwyer Kaluzna(@StephDwyer21) 's Twitter Profile Photo

New Guidelines! 🫀

Reviewing this guideline is absolutely the peak of my career. A lot of important updates in this long-awaited guideline!

account_circle
ACCP Cardiology PRN(@accpcardprn) 's Twitter Profile Photo

Join us for the next Cardiology PRN JC on Nov 30 @ 3 PM EST. We'll be talking IV iron in HF with PGY2 CV residents Drs. Kyndol Craver and Laura Andino as they review AFFIRM-AHF and HEART-FID. See you there!
uic.zoom.us/j/83242401765?…
Meeting ID: 832 4240 1765, Passcode: SVZ6EHf2

account_circle
Stephanie Dwyer Kaluzna(@StephDwyer21) 's Twitter Profile Photo

one of the most important things I’ve learned as a working parent is to appreciate the power of the word “and”.

I enjoy my work AND I miss my kids during the day. The initial back to work time is hard AND I will find my groove again.

account_circle
Stephanie Dwyer Kaluzna(@StephDwyer21) 's Twitter Profile Photo

🚨 WE’RE RECRUITING 🚨

The UIC Dept Pharmacy Practice members are recruiting for our 2024-2025 PGY2 Cardiology Pharmacy Resident 🫀💊

For those attending Midyear, I’d love to chat then. For those not attending, please DM me or email me to set up another time. Can’t wait to meet ya!

🚨 WE’RE RECRUITING 🚨 The @UICPhPr #TeamMRA members are recruiting for our 2024-2025 PGY2 Cardiology Pharmacy Resident 🫀💊 For those attending Midyear, I’d love to chat then. For those not attending, please DM me or email me to set up another time. Can’t wait to meet ya!
account_circle
Stephanie Dwyer Kaluzna(@StephDwyer21) 's Twitter Profile Photo

check out JinJoo’s (UIC Dept Pharmacy Practice PGY2 Cardiology Resident) review of 1Cs! lots of great clinical pearls condensed into just two pages 🫀💊

account_circle
Dana Johnson MD MPH(@rainylakedana) 's Twitter Profile Photo

We’re looking for a new EP APRN to join our growing electrophysiology team at UIC! DM me for details! UI Health⁩ ⁦UIC Cardio Fellows⁩ uic.csod.com/ux/ats/careers…

account_circle
Zachary Cox(@Zac0x) 's Twitter Profile Photo

DICTATE-AHF top line results were presented at KEY MESSAGE: Dapagliflozin is safe to start on the first day of AHF hospitalization to optimize Addironally, diuretic benefits have meaningful impact on AHF discharge rates over the study period

DICTATE-AHF top line results were presented at #ESCCongress2023 KEY MESSAGE: Dapagliflozin is safe to start on the first day of AHF hospitalization to optimize #gdmt Addironally, diuretic benefits have meaningful impact on AHF discharge rates over the study period
account_circle
European Society of Cardiology(@escardio) 's Twitter Profile Photo

Early initiation of the sodium glucose co-transporter 2 ( ) inhibitor dapagliflozin did not result in a statistically significant improvement in diuretic efficiency relative to structured usual care in hospitalised patients with acute decompensated heart failure (ADHF).

Early initiation of the sodium glucose co-transporter 2 (#SGLT2) inhibitor dapagliflozin did not result in a statistically significant improvement in diuretic efficiency relative to structured usual care in hospitalised patients with acute decompensated heart failure (ADHF).
account_circle
European Society of Cardiology(@escardio) 's Twitter Profile Photo

A pragmatic natriuresis guided diuretic approach in patients with acute significantly increases 24-hour natriuresis without impacting all-cause mortality or heart failure rehospitalisation.

PUSH-AHF trial - Natriuresis guided therapy in acute heart

A pragmatic natriuresis guided diuretic approach in patients with acute #heartfailure significantly increases 24-hour natriuresis without impacting all-cause mortality or heart failure rehospitalisation. #ESCCongress PUSH-AHF trial - Natriuresis guided therapy in acute heart
account_circle
UIC Pharmacy(@UICPharm) 's Twitter Profile Photo

Candice Schaper, MSN, UCAN Flight RN (Candice Schaper) did not stay in the periphery when discussing the need for central access for vasoactive agents.

'Consider the trial definitions of 'adverse events''

Candice Schaper, MSN, UCAN Flight RN (@caschaper) did not stay in the periphery when discussing the need for central access for vasoactive agents. 'Consider the trial definitions of 'adverse events'' #C42023
account_circle
UIC Pharmacy(@UICPharm) 's Twitter Profile Photo

Dr. Shannon Lovett highlights the necessity of clear and succinct language during cardiopulmonary resuscitation and the importance of PharmD code response.

Dr. Shannon Lovett highlights the necessity of clear and succinct language during cardiopulmonary resuscitation and the importance of PharmD code response. #C42023
account_circle